https://sputnikglobe.com/20230412/biden-administration-declares-fentanyl-xylazine-emerging-threat-to-us-1109398796.html
Biden Administration Declares Fentanyl-Xylazine 'Emerging Threat' to US
Biden Administration Declares Fentanyl-Xylazine 'Emerging Threat' to US
Sputnik International
The Biden administration has designated xylazine combined with fentanyl an "emerging threat" to the United States for their significant and worsening negative health consequences on the country's population, Office of National Drug Control Policy (ONDCP) Director Rahul Gupta said on Wednesday.
2023-04-12T16:52+0000
2023-04-12T16:52+0000
2023-04-12T16:52+0000
americas
us
fentanyl
https://cdn1.img.sputnikglobe.com/img/07e5/0c/13/1091636416_0:231:2730:1767_1920x0_80_0_0_51c945c70d53bdbaf069c2bfb2f7b3cb.jpg
"By declaring xylazine combined with fentanyl as an emerging threat, we are being proactive in our approach to save lives and creating new tools for public health and public safety officials and communities across the Nation. To parents, loved ones, community leaders, and those affected by xylazine use: I want you to know that help is on the way," Gupta said. Gupta pointed out that as a physician he is deeply troubled about the devastating impact of the fentanyl-xylazine combination, adding that he is immensely concerned about what the threat means for the United States. President Joe Biden's drug policy adviser also noted this is the first time that federal officials have used the designation authority since Congress passed it in 2018. The Biden administration has said it will take steps to publicize a comprehensive government response that includes evidence-based prevention, treatment and supply reduction of fentanyl-xylazine in the United States. Meanwhile, ONDCP is set to convene an interagency working group to develop a national response plan to the newly declared threat, including creating protocols on testing, treatment and supportive care, among other measures.
https://sputnikglobe.com/20230408/cocaine--crack-are-back-in-nyc-and-fentanyl-makes-everything-much-worse---reports-1109281968.html
americas
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2023
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
us, biden administration, fentanyl, emerging threat
us, biden administration, fentanyl, emerging threat
Biden Administration Declares Fentanyl-Xylazine 'Emerging Threat' to US
WASHINGTON (Sputnik) - The Biden administration has designated xylazine combined with fentanyl an "emerging threat" to the United States for their significant and worsening negative health consequences on the country's population, Office of National Drug Control Policy (ONDCP) Director Rahul Gupta said on Wednesday.
"By declaring xylazine combined with fentanyl as an emerging threat, we are being proactive in our approach to save lives and creating new tools for public health and public safety officials and communities across the Nation. To parents, loved ones, community leaders, and those affected by xylazine use: I want you to know that help is on the way," Gupta said.
Gupta pointed out that as a physician he is deeply troubled about the
devastating impact of the fentanyl-xylazine combination, adding that he is immensely concerned about
what the threat means for the United States.
President
Joe Biden's drug policy adviser also noted this is the first time that federal officials have used the designation authority since Congress passed it in 2018.
The Biden administration has said it will take steps to publicize a comprehensive government response that includes evidence-based prevention, treatment and supply reduction of fentanyl-xylazine in the United States.
Meanwhile, ONDCP is set to convene an interagency working group to develop a national response plan to the newly declared threat, including creating protocols on testing, treatment and supportive care, among other measures.
